Articles

India's manufacturing footprint is expanding, biosimilars are gaining momentum, and FDA inspections are evolving. The latest U.S. pharmaceutical quality report offers important insights for Indian manufacturers, exporters, regulators, and pharmacy professionals.

The question that hit our mind is, why are so many drug samples failing quality tests in india? Is it normal or does the pharmaceutical industry need to improve?

Oral GLP-1 therapy is bringing obesity treatment to millions of patients who had never used weight-loss medicines before

The obesity treatment landscape is changing at remarkable speed, and Novo Nordisk has just added another milestone to the story.

The Danish pharmaceutical giant announced that Wegovy® (semaglutide) tablets 25 mg have surpassed 3 million prescriptions in the United States within just over five months of launch, making it one of the strongest pharmaceutical product launches by prescription volume in recent U.S. history.

Billions in Planned Investments Are Being Delayed, Reduced, or Redirected as Pharmaceutical Companies Reassess Europe’s Competitiveness.

For decades, Europe has been one of the world's leading destinations for pharmaceutical research, manufacturing, and innovation. Germany has long been regarded as the manufacturing powerhouse of the European pharmaceutical industry, while the United Kingdom has served as a global center for life sciences research and drug development.

Human Papillomavirus (HPV) remains one of the most common viral infections worldwide and is strongly associated with cervical cancer. While preventive HPV vaccines have transformed public health strategies, effective treatment options for existing HPV infections and precancerous cervical lesions continue to be an active area of research.

About Authors
Harsh Bhardwaj1, Muskan Baller2, Rupali Dilip Taru3, Raaz K Maheshwari4

About Authors
Harsh Bardwaj¹*, Monika CHamoli2, Raaz K Maheshwari3
Assistant Professor, Department of Chemistry, Shri Ratanlal Kanwarlal Patni Girls’ College, Kishangarh, Ajmer, Rajasthan, India

Harsh Bhardwaj1*, Sakshi Jain2, Raaz K Maheshwari3
1Assistant Professor, Department of Chemistry, Shri RK Patni Girls’ College, Kishangarh, Ajmer, Rajasthan, India

In the 1970s, India was facing a silent epidemic of cataract blindness. Millions of elderly people were losing their eyesight, not because treatment was unavailable, but because it was unaffordable. Cataract surgery required replacing the cloudy natural lens with a clear artificial intraocular lens (IOL). At that time, these lenses were imported and cost nearly 100 US dollars each, far beyond the reach of poor patients.

At the center of the solution was a remarkable man, Dr. Govindappa Venkataswamy, lovingly known as Dr. V.